Welcome to the First Edition of Our People Pathways Newsletter for 2026!
For more than twenty years, Isogenica has built deep expertise and knowledge about how to find VHH antibodies and develop them into drugs in partnership with some of the world’s most innovative biopharma companies. As our Laboratory Assistant, you will help support our scientific team to create the next generation of life-changing medicines.
Want to turn world-changing research into world-changing impact?
Cambridge Enterprise is looking for someone who can open doors, spark conversations, and help brilliant researchers see the commercial potential in their work. If you can walk into a lab, understand the science, and show academics how their discoveries could change lives - whilst building genuine relationships across one of the world's leading universities - this role is for you
Why you will love this role:
Sandwich, UK - 18 February 2026: Discovery Park and University of Kent will host their third joint Innovation Showcase on Thursday, 5th March, bringing together academics, industry, clinical partners and funders.
The showcase explores the progress and impact of research projects funded through the Kent UKRI Impact Acceleration Accounts (IAAs), a strategic investment programme designed to accelerate the real-world impact of research.
The Antibody Series stands at the forefront of antibody science—an energizing event designed to inspire collaboration and accelerate innovation. Hosted in the medieval city of Évora, this conference will bring together global leaders across biotech, pharmaceutical, venture capital, and academic sectors, for an intensive four-day programme dedicated to antibody discovery and development.
You can’t miss this opportunity to connect with visionaries, cutting-edge content, strategic networking and prime location.
Canary Wharf Group and L39 are once again hosting the popular Fin|Tech| Bio on Tuesday 24th February. The topic is ‘The Future of Data and Cross-Sector Synergies’ and the themes will cover data as a catalyst, governance and compliance and emerging technologies.
New Collaboration Brings GOLD Protein–Ligand Docking Capabilities to Sapio ELaiN — the World’s First 3rd‑Generation AI Laboratory Notebook
The Cambridge Crystallographic Data Centre (CCDC), a global leader in structural chemistry data, software, and services, today announced a new strategic technology partnership with Sapio Sciences.
As humanity prepares for long-duration space missions, one of the greatest obstacles lies not only in rockets and satellites but in our own biology. Space travel exposes the human body to unique challenges, including microgravity, hypo-gravity and cosmic radiation, which accelerate aging and cause organ damage.
Constructive Bio is a VC-backed biotechnology startup based in Whittlesford, Cambridge. Our unique technology turns living cells into biofactories, creating sustainable new materials and therapeutics. With full control of the genetic sequence and code, we are exploring chemical space previously unreached by natural biology.
At Cancer Research UK, we exist to beat cancer.
We have an exciting opportunity for a Senior Grants Manager to join Cancer Grand Challenges and lead on grant and funding operations across the Research Team including through open funding calls and review / stewardship of research teams supporting Cancer Grand Challenges’ mission.